These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8082567)

  • 1. Mutational spectrum of the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
    Lehman TA; Greenblatt M; Bennett WP; Harris CC
    Drug Metab Rev; 1994; 26(1-2):221-35. PubMed ID: 8082567
    [No Abstract]   [Full Text] [Related]  

  • 2. Functional inactivation but not structural mutation of p53 causes liver cancer.
    Ueda H; Ullrich SJ; Gangemi JD; Kappel CA; Ngo L; Feitelson MA; Jay G
    Nat Genet; 1995 Jan; 9(1):41-7. PubMed ID: 7704023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma.
    Nishida N; Fukuda Y; Kokuryu H; Toguchida J; Yandell DW; Ikenega M; Imura H; Ishizaki K
    Cancer Res; 1993 Jan; 53(2):368-72. PubMed ID: 8093350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation of p53 gene in hepatocellular carcinoma in Taiwan.
    Sheu JC; Huang GT; Lee PH; Chung JC; Chou HC; Lai MY; Wang JT; Lee HS; Shih LN; Yang PM
    Cancer Res; 1992 Nov; 52(21):6098-100. PubMed ID: 1327523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infrequent mutation of p53 gene in hepatitis B virus positive primary hepatocellular carcinomas.
    Hosono S; Chou MJ; Lee CS; Shih C
    Oncogene; 1993 Feb; 8(2):491-6. PubMed ID: 8093978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The relation between p53 mutations and tumor invasiveness of human hepatocellular carcinoma].
    Qin L; Tang Z; Liu K
    Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):405-8. PubMed ID: 8697987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the tumor suppressor gene p53 in human liver cancer induced by alpha-particles.
    Andersson M; Jönsson M; Nielsen LL; Vyberg M; Visfeldt J; Storm HH; Wallin H
    Cancer Epidemiol Biomarkers Prev; 1995; 4(7):765-70. PubMed ID: 8672994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloning and expression of CD24 gene in human hepatocellular carcinoma: a potential early tumor marker gene correlates with p53 mutation and tumor differentiation.
    Huang LR; Hsu HC
    Cancer Res; 1995 Oct; 55(20):4717-21. PubMed ID: 7553654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular carcinoma mutation.
    Hayward NK; Walker GJ; Graham W; Cooksley E
    Nature; 1991 Aug; 352(6338):764. PubMed ID: 1652691
    [No Abstract]   [Full Text] [Related]  

  • 10. TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer.
    Hussain SP; Schwank J; Staib F; Wang XW; Harris CC
    Oncogene; 2007 Apr; 26(15):2166-76. PubMed ID: 17401425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Alteration of genomic structure and/or expression of cancer associated genes in hepatocellular carcinoma].
    Fujimoto Y; Kohgo Y
    Rinsho Byori; 1998 Jan; 46(1):9-14. PubMed ID: 9492532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas.
    Murakami Y; Hayashi K; Hirohashi S; Sekiya T
    Cancer Res; 1991 Oct; 51(20):5520-5. PubMed ID: 1655254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic aberration in primary hepatocellular carcinoma: correlation between p53 gene mutation and loss-of-heterozygosity on chromosome 16q21-q23 and 9p21-p23.
    Wang G; Huang CH; Zhao Y; Cai L; Wang Y; Xiu SJ; Jiang ZW; Yang S; Zhao T; Huang W; Gu JR
    Cell Res; 2000 Dec; 10(4):311-23. PubMed ID: 11191353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship between mutation of tumor suppressor gene p53 and development of hepatocellular carcinoma].
    Zhu MH
    Zhonghua Zhong Liu Za Zhi; 1993 Jul; 15(4):245-7. PubMed ID: 7909744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor progression in hepatocellular carcinoma may be mediated by p53 mutation.
    Tanaka S; Toh Y; Adachi E; Matsumata T; Mori R; Sugimachi K
    Cancer Res; 1993 Jun; 53(12):2884-7. PubMed ID: 8389246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
    Greenblatt MS; Bennett WP; Hollstein M; Harris CC
    Cancer Res; 1994 Sep; 54(18):4855-78. PubMed ID: 8069852
    [No Abstract]   [Full Text] [Related]  

  • 17. Mutagenesis of the H-ras protooncogene and the p53 tumor suppressor gene.
    Cerutti P; Hussain P; Pourzand C; Aguilar F
    Cancer Res; 1994 Apr; 54(7 Suppl):1934s-1938s. PubMed ID: 7907948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational hotspot in the p53 gene in human hepatocellular carcinomas.
    Hsu IC; Metcalf RA; Sun T; Welsh JA; Wang NJ; Harris CC
    Nature; 1991 Apr; 350(6317):427-8. PubMed ID: 1849234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation pattern of the p53 gene as a diagnostic marker for multiple hepatocellular carcinoma.
    Oda T; Tsuda H; Scarpa A; Sakamoto M; Hirohashi S
    Cancer Res; 1992 Jul; 52(13):3674-8. PubMed ID: 1319827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 gene in hepatocellular carcinomas from Australia.
    Vesey DA; Hayward NK; Cooksley WG
    Cancer Detect Prev; 1994; 18(2):123-30. PubMed ID: 8025894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.